Ben Willcox

Find out more and register at: bit.ly/3GfxpBt

Want to get up to speed with immune checkpoint blockade therapy for cancer ? Register now for this online 13-hour CPD course ‘Understanding immune checkpoint blockade therapy: a pillar of modern cancer treatment’, from the University of Birmingham, UK, starting on Jan 24th, 2024.

@forum_gd @ErinJAdams Great talks ! A q. for Erin...What is the phenotype of the CD1-reactive Vδ1 cells (eg Tnaive vs Teffector) ?? Given huge diversity in the Vδ1 TCR repertoire and in the CD1 binding modes, do some reflect the ‘universe of possibilities’ – rather than Teffector specificities ??

Exciting day for us launching our new #DiversityandInclusion framework! I’m so proud of the team and our membership for all we’ve done to date, but there’s always more we can do. Have a read to see how we are going to take this forward with our members and wonderful community 👇

26 years ago, a gunman entered Dunblane Primary School in Scotland, killing 16 kids and a teacher. The UK govt responded by enacting tight gun control legislation. In the 9400+ days since, there have been a total of O school shootings in the UK. #Uvalde

Great to get McMurray et al out in Cell Reports, a page turner about transcriptional control of adaptive gd T cells. Thx to all co-authors and congrats to the talented @JackMcMurray. Strong similarities to ab T cells bring things back to ligand recognition as key gd USP.

@forum_gd Super-impressive paper (Singh et al) in Nature on a new ‘immunoantibiotic’ approach to tackle drug resistant microbes, which enlists the help of Vγ9Vδ2 T cells. Here is our News and Views, co-authored with @Youcef_Mehellou go.nature.com/3bvqshm

An ‘immunoantibiotic’ drug launches a two-pronged attack on antibiotic-resistant microbes. Learn more this terrific N&V by @Youcef_Mehellou & @profbenw go.nature.com/3bvqshm

Super-impressive study by Singh et al in Nature on an ‘immunoantibiotic’ approach to tackle drug resistant microbes, enlisting help from γδ T cells. Check out our News and Views, co-authored with @Youcef_Mehellou. go.nature.com/3bvqshm @NatureNV @ImmunologyUoB @IMIBirmingham

Massive congratulations to David Bending for scooping an MRC Career Development Fellowship ! Great to see a young scientist get career-changing support. So happy for him and @BendingLab.

Signed, sealed, delivered, installed and operational ! Thanks to @menala76 and the GE team for setting up our new ÄKTA Pure. Here's to the next 17 years ! #AKTA #chromatography #proteinpurification

In case you've been wondering what γδ T cells have been getting up to over the last 500m years, check out our latest review.

@CRUKResearch Extremely informative visit to the CRUK Birmingham Centre from CRUK’s CDD team and the CRUK-Astra Zeneca Antibody Alliance Laboratory yesterday. Many thanks to Nigel Blackburn, Rob Williams and Julie Little for helping us take our research from lab to patient !

Check out our new paper in Immunity 👉🏻 “Butyrophilin-like 3 Directly Binds a Human Vγ4+ T Cell Receptor Using a Modality Distinct from Clonally-Restricted Antigen” cell.com/immunity/fullt… • #gdTcells @forum_gd @unibirm_MDS @CIIC_UoB @ImmunologyUoB @ImmunityCP #immunology #Tcells

@StridLab Thanks Jessica, yes it will be fun to see how far this superantigen-like paradigm takes us all. It was great to work with the Haydays on this !

@CoffeltLab Thanks Seth - glad you like and hope all is well !

Read our Nat Comm study suggesting some human gamma delta T cells are MUCH more adaptive than thought ! bit.ly/2lDzNab #immunology

@wellcometrust Thanks 4 funding my best research paper ever ! Starting 2 decipher gamma delta T cells. bit.ly/2lDzNab #immunology😀

Mike Stubbington (Sanger Centre), seminar: “Exploring T cell fate and clonality using single cell transcriptomes”. TODAY Mon 9th S104, 3pm

Welcome to Week 2 of our Cancer Immunotherapy MOOC at Future Learn.Q: Why is cancer such a challenge for the immune system? #FLCancerTherapy